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2The pathogenesis of common cold infection is not well-understood. Apparently the viral infection per
se is not the principal reason for the symptoms. For example a rhinovirus infection does not produce
detectable cytopathic effects on a monolayer culture of nasal epithelial cells (1). Instead it has been
suggested that exaggerated host responses may play a crucial role in the pathogenesis. Neutrophils
infiltrate the nasal mucosa early in the course of infection (2), and there is a significant correlation
between the number of neutrophils in the nasal lavages and the severity of symptoms of rhino-virus
infection (3). In general immunocomplexes are efficient activators of neutrophil respiratory burst (the
production of superoxide and other oxidants derived thereof). For example the respiratory syncytial
virus-antibody complex activates the respiratory burst of neutrophils, and it has been suggested that
the released oxidants may play a role in the pathogenesis of the respiratory syncytial virus infection
(4).
If the generation of oxidants by neutrophils is a partial cause of the symptoms of an
infection, then the symptoms should be ameliorated by decreasing the steady state oxidant levels. In
fact this has been observed in mice infected with influenza virus (5). Superoxide production by
phagocytes was increased severalfold by the infection. It is noteworthy that the mortality caused by
influenza was significantly decreased in mice injected with superoxide dismutase, a super-oxide-
degrading enzyme. Accordingly the oxygen radicals may have a role in respiratory virus infections in
vivo, even though one must be prudent when extrapolating characteristics of the human common cold
from those of influenza in mice.
Vitamin C is a major antioxidant in human plasma (6); therefore it may be an important
physiologic factor in counteracting the oxidants released by the neutrophils. Activation of neutrophils
in vitro causes rapid oxidation of extracellular vitamin C, which suggests that high concentrations of
the vitamin should provide protection against the damage caused by the oxidants released in vivo (7).
If oxidants produced by neutrophils play a role in the pathogenesis of the common cold, then one
would expect that (a) vitamin C metabolism changes during the common cold and (b) vitamin C
supplementation ameliorates the symptoms of the common cold.
During a common cold the vitamin C concentration in leukocytes and the amount of the
vitamin excreted in urine decreases (8). Moreover although large intakes (4 to 10 g/day) of vitamin C
typically cause stomach ailments such as diarrhea among healthy people, persons who have caught a
common cold may ingest over 30 g/day without apparent overdosage problems (9). This variation is
further evidence of changes in vitamin C metabolism in people infected with common cold viruses.
Regarding the second point about 20 double blind studies have consistently shown that
vitamin C decreases the duration or severity of common cold episodes (8). Although vitamin C
participates in several other reactions in the body, in addition to the antioxidant reactions, none of the
other reactions appears to be a likely explanation for the amelioration of symptoms (8). Accordingly
the results of the intervention studies with vitamin C are consistent with the hypothesis that
neutrophil activation is partially responsible for the symptoms of the common cold.
The precise clinical significance of the role of vitamin C in the common cold cannot be
clearly inferred from the studies conducted, since a large variation has been observed in the
beneficial effects of the vitamin (8). On the other hand there are some data to suggest that more
benefit could be obtained from vitamin C doses higher than those used in the controlled studies (8,9).
Apparently various viral and bacterial infections may lead to the activation of neutrophils;
thus the potential uses of vitamin C should not be limited to the common cold. Several studies have
indicated that vitamin C may also ameliorate the symptoms of various viral and bacterial infections
(for a review see Reference 10). However, these studies are 30 to 60 years old (10) and there seem to
be no recent, thorough studies on infections other than those of the common cold viruses. Still it has
quite recently been suggested that large amounts of vitamin C may be beneficial for patients with
bacterial infections (9).
Obviously the role of vitamin C in infections should be studied in more detail. The common
cold studies indicate that prevention of scurvy is not the sole physiologic role of vitamin C.
Furthermore in several disease conditions, such as the common cold, the level of intake of the
vitamin derived from a normal diet may be insufficient for the best functioning of the body.
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